1. Provide a clinical focus on disorders whose aetiology may be related to bowel flora.

2. Carry out clinical trials and collect data on use of various probiotics, predominantly in the treatment of GI disorders.

3. Diagnose and treat disorders characterised by abnormal bowel flora.

4. Treat various GI disorders by making available probiotic products ranging from single probiotics, through to mixed products and ultimately to the provision of Human Probiotic Infusions.

5. To develop novel probiotics for various disease states and to trial these in clinical practice.